[Study of plasma ACTH in 100 human lysine-vasopressin tests].
D000224:Addison Disease / Q000097:blood; D000293:Adolescent; D000307:Adrenal Gland Diseases / Q000097:blood; D000311:Adrenal Glands / Q000187:drug effects; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000494:pharmacology; D000328:Adult; D000368:Aged; D002648:Child; D003480:Cushing Syndrome / Q000097:blood; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D005470:Fluorometry; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006965:Hyperplasia / Q000097:blood; D007018:Hypopituitarism / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007273:Injections, Intramuscular; D008239:Lysine / Q000494:pharmacology; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood; D010912:Pituitary-Adrenal Function Tests; D014667:Vasopressins / Q000494:pharmacology*
D014667:Vasopressins; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008239:Lysine; D006854:Hydrocortisone; D008797:Metyrapone
Etude de l'ACTH plasmatique au cours de 100 epreuves a la lysine-vasopressine chez l'homme.